MICAL1 - microtubule associated monooxygenase, calponin and LIM domain containing 1 Gene
Also Known as MICAL; NICAL; MICAL-1
Species: Homo sapiens
About MICAL1
This gene has 8 transcripts (splice variants), 198 orthologues, 36 paralogues and is associated with 1 phenotype. Ubiquitous expression in bone marrow (RPKM 31.4), lymph node (RPKM 25.8) and 23 other tissues.
Summary
This gene encodes an enzyme that oxidizes methionine residues on actin, thereby promoting depolymerization of actin filaments. This protein interacts with and regulates signalling by NEDD9/CAS-L (neural precursor cell expressed, developmentally down-regulated 9). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
MICAL1 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001159291.2 | NP_001152763.1 | [F-actin]-monooxygenase MICAL1 isoform 2 |
| NM_001286613.2 | NP_001273542.1 | [F-actin]-monooxygenase MICAL1 isoform 3 |
| NM_022765.4 | NP_073602.3 | [F-actin]-monooxygenase MICAL1 isoform 1 |
MICAL1 Protein Structure
FAD_binding_3: FAD binding domain (85 - 122)
CH: Calponin homology (CH) domain (512 - 610)
LIM: LIM domain (697 - 750)
DUF3585: Protein of unknown function (DUF3585) (926 - 1059)
- 0
- 200
- 400
- 600
- 800
- 1000
- 1067 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
[F-actin]-monooxygenase MICAL1 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Epilepsy, Familial Temporal Lobe, 1 |
|
|
| Epilepsy, Familial Temporal Lobe, 7 |
|
|
| Cerebral Amyloid Angiopathy, Itm2b-Related, 1 |
|
|
| Diseases | Alias | |
|---|---|---|
| Waldenstroem'S Macroglobulinemia |
Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-B2176 | ATP | 99.88% | Unkown | |
| HY-13757 | Tamoxifen Citrate | 99.88% | Yes | |
| HY-12678 | Entrectinib | 99.26% | Yes | |
| HY-109506 | DPPC | 99.91% | Unkown | |
| HY-B1192 | Estradiol benzoate | Agonist | 99.90% | Unkown |
| HY-109044 | Tapinarof | Agonist | 99.95% | Unkown |
| HY-B0448 | Phenytoin | Inhibitor | 99.95% | Yes |
| HY-B1005 | 8-Hydroxyquinoline | Inhibitor | 99.99% | Unkown |
| HY-B0892 | Benzyl alcohol | 99.99% | Unkown | |
| HY-B0693 | Ranitidine | Antagonist | 99.9% | Yes |
| HY-B0448A | Phenytoin sodium | Inhibitor | 99.78% | Yes |
| HY-B0111 | Drospirenone | Agonist | 99.95% | Unkown |
| HY-124290 | Carotegrast methyl | Antagonist | 99.24% | Unkown |
| HY-B0344 | Methscopolamine bromide | Inhibitor | 99.81% | Unkown |
| HY-B1198 | Piperonyl butoxide | Inhibitor | 98.0% | Unkown |
| HY-B0281A | Ranitidine hydrochloride | Antagonist | 99.86% | Yes |
| HY-B0417A | Lincomycin hydrochloride | Inhibitor | 99.59% | Unkown |
| HY-B1350A | Fusidic acid sodium salt | Inhibitor | 99.64% | Yes |
| HY-B1358 | Lincomycin hydrochloride monohydrate | Inhibitor | 99.74% | Unkown |
| HY-B1640R | Ethacrynic acid (Standard) | Inhibitor | 98.78% | Unkown |
| HY-117660 | Lincomycin | Inhibitor | 99.82% | Unkown |
| HY-13859 | Clevudine | Inhibitor | 99.84% | Unkown |
| HY-B1268 | Docusate Sodium | Inhibitor | 98.0% | Unkown |
| HY-P0009 | Cetrorelix | Antagonist | 99.71% | Yes |
| HY-12752A | Alimemazine hemitartrate | 99.49% | Unkown | |
| HY-B0921 | Succinylsulfathiazole | Inhibitor | 99.75% | Unkown |
| HY-B0693A | Ranitidine bismuth citrate | / | Unkown | |
| HY-B1198R | Piperonyl butoxide (Standard) | Inhibitor | / | Unkown |
| HY-B1640A | Ethacrynic acid sodium | Inhibitor | / | Unkown |
| HY-133171A | (S)-Norfluoxetine | Inhibitor | / | Unkown |
| HY-B0430B | (±)-Pantothenic acid | / | Unkown |
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9944 | Palivizumab | Inhibitor | 99.63% | Unkown |
| HY-P99797 | Pabinafusp alfa | 98.89% | Unkown |
Clinical Phase
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase |
|---|---|---|---|---|
| HY-B1946 | Dimethoate | 99.91% | Phase 4 | |
| HY-N6869 | Dehydroabietic acid | 98.52% | Phase 4 | |
| HY-163885 | SSZ | Inhibitor | 98.13% | Phase 4 |
| HY-124290A | Carotegrast methyl hydrochloride | Antagonist | / | Phase 4 |
| HY-10484 | Pevonedistat hydrochloride | 99.19% | Phase 3 | |
| HY-123475 | Sisunatovir | Inhibitor | 99.40% | Phase 3 |
| HY-145721 | Mongersen | Inhibitor | 98.57% | Phase 3 |
| HY-106837 | Israpafant | Antagonist | / | Phase 3 |
| HY-138842 | DDN | Activator | / | Phase 3 |
| HY-176127 | JX10 | Inhibitor | / | Phase 3 |
| HY-100442 | Paquinimod | Inhibitor | 99.90% | Phase 2 |
| HY-10367 | Canertinib | Inhibitor | 99.74% | Phase 2 |
| HY-141523 | Vociprotafib | Inhibitor | 99.70% | Phase 2 |
| HY-14530 | Pelitrexol | 98.07% | Phase 2 | |
| HY-129239 | Farudodstat | 99.68% | Phase 2 | |
| HY-160023 | Elisrasib | 99.68% | Phase 2 | |
| HY-103400 | 8-Chloroadenosine | 99.75% | Phase 2 | |
| HY-18099 | S1RA | Antagonist | 98.96% | Phase 2 |
| HY-120083 | Rodatristat | Inhibitor | 98.41% | Phase 2 |
| HY-137440A | Firazorexton hydrate | 99.94% | Phase 2 | |
| HY-106887 | SCH 32615 | 99.68% | Phase 2 | |
| HY-168739 | Topoisomerase I inhibitor 17 | / | Phase 2 | |
| HY-116175 | BIBB 515 | 99.56% | Phase 1 | |
| HY-125639 | (rac)-AR-13503 | Inhibitor | 99.08% | Phase 1 |
| HY-P10032 | NN1177 | 99.54% | Phase 1 | |
| HY-115681 | (2R/S)-6-PNG | Inhibitor | 99.96% | Phase 1 |
| HY-111792 | GSK1795091 | Agonist | 94.48% | Phase 1 |
| HY-106925 | Cetefloxacin | Inhibitor | / | Phase 1 |
| HY-117630 | RB-6145 | / | Phase 1 | |
| HY-101699A | AMG-076 | Antagonist | / | Phase 1 |
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase |
|---|---|---|---|---|
| HY-P9983 | Lintuzumab | Inhibitor | 98.09% | Phase 3 |
| HY-P99744 | Modakafusp alfa | Inhibitor | 96.22% | Phase 2 |
| HY-P991961 | REGN4659 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-70062 | Pevonedistat | 99.98% | Unkown | |
| HY-14452 | Fatostatin | Inhibitor | 99.85% | Unkown |
| HY-N0219 | Bicuculline | Antagonist | 99.98% | Unkown |
| HY-134901 | WM-3835 | 99.78% | Unkown | |
| HY-160769 | NIBR-LTSi | 99.97% | Unkown | |
| HY-131042 | NNMTi | Inhibitor | 99.70% | Unkown |
| HY-110171 | iMDK | Inhibitor | 99.35% | Unkown |
| HY-113354 | Anserine | 99.85% | Unkown | |
| HY-160818 | MC3138 | Activator | 99.92% | Unkown |
| HY-N2342 | Procyanidin C1 | Inducer | 99.54% | Unkown |
| HY-120912 | Gingerenone A | Activator | 99.95% | Unkown |
| HY-103124 | DOI hydrochloride | Agonist | 99.61% | Unkown |
| HY-14452A | Fatostatin hydrobromide | Inhibitor | 99.52% | Unkown |
| HY-143228 | SH-42 | Inhibitor | 99.87% | Unkown |
| HY-103157 | PD146176 | 99.59% | Unkown | |
| HY-156856 | FL118-14-Propanol | 99.56% | Unkown | |
| HY-135747 | Gut restricted-7 | Inhibitor | 99.54% | Unkown |
| HY-126255 | SBI-797812 | Activator | 99.88% | Unkown |
| HY-P1925A | GO-203 TFA | 98.39% | Unkown | |
| HY-137207 | MK-28 | Activator | 99.88% | Unkown |
| HY-103017A | JH-X-119-01 | Inhibitor | 99.65% | Unkown |
| HY-114169 | WRG-28 | Inhibitor | 99.76% | Unkown |
| HY-131181 | LEI-401 | Inhibitor | 99.73% | Unkown |
| HY-161834 | RG100204 | Inhibitor | 99.50% | Unkown |
| HY-113365 | Cholestenone | 99.95% | Unkown | |
| HY-125474 | Carrageenan | Inhibitor | / | Unkown |
| HY-108559 | L-161982 | Inhibitor | 99.33% | Unkown |
| HY-117427 | D5D-IN-326 | 99.90% | Unkown | |
| HY-P1587 | IRBP (1-20), human | 99.58% | Unkown | |
| HY-156117 | LB244 | Inhibitor | 98.45% | Unkown |
| HY-134494 | MS48107 | 99.90% | Unkown | |
| HY-124284 | Hexamethylene bisacetamide | 99.56% | Unkown | |
| HY-111754 | DMX-5804 | Inhibitor | 99.64% | Unkown |
| HY-W010042 | L-Glucose | 99.90% | Unkown | |
| HY-110171A | iMDK quarterhydrate | Inhibitor | 99.37% | Unkown |
| HY-145721A | Mongersen sodium | 99.61% | Unkown | |
| HY-N8522 | 9,10-Dihydroxystearic acid | 98.0% | Unkown | |
| HY-P1290A | PKA Inhibitor Fragment (6-22) amide TFA | Inhibitor | 99.77% | Unkown |
| HY-P1136C | TAT-Gap19 TFA | 99.41% | Unkown | |
| HY-103111 | MMPIP hydrochloride | Antagonist | 98.31% | Unkown |
| HY-101404A | L-Homocysteine thiolactone hydrochloride | 99.99% | Unkown | |
| HY-147323 | Ferulic acid 4-O-sulfate | 98.86% | Unkown | |
| HY-110190 | VU0422288 | Modulator | 99.94% | Unkown |
| HY-N1388 | Tussilagone | 99.52% | Unkown | |
| HY-P1136B | TAT-Gap19 | 99.60% | Unkown | |
| HY-120597 | SAK3 | Activator | 99.80% | Unkown |
| HY-121675 | 2-Bromo-LSD | 97.26% | Unkown | |
| HY-B0708 | β-Estradiol 17-acetate | Agonist | 99.93% | Unkown |
| HY-W013411A | Locostatin | 99.88% | Unkown | |
| HY-129297 | CMPF | 99.64% | Unkown | |
| HY-19350 | BML-210 | 98.04% | Unkown | |
| HY-B1002 | Oxolinic acid | Inhibitor | 98.97% | Unkown |
| HY-W015635 | Diallyl disulfide | Inhibitor | 99.8% | Unkown |
| HY-B2176I | ATP disodium salt, 100 mM Solution, PCR Grade | / | Unkown | |
| HY-101029 | MBM-55 | 99.94% | Unkown | |
| HY-127034 | Antipain dihydrochloride | Inhibitor | 99.9% | Unkown |
| HY-N2189 | Swertisin | 99.54% | Unkown | |
| HY-114918 | MS438 | Agonist | 99.85% | Unkown |
| HY-125130 | Hesperetin 7-O-glucoside | Inhibitor | 99.38% | Unkown |
| HY-171034 | PQA-18 | Inhibitor | 99.62% | Unkown |
| HY-103017 | JH-X-119-01 hydrochloride | Inhibitor | 99.14% | Unkown |
| HY-10367A | Canertinib dihydrochloride | Inhibitor | 99.68% | Unkown |
| HY-161305 | SE-7552 | Inhibitor | 99.48% | Unkown |
| HY-119347 | Cirsilineol | Inhibitor | 98.0% | Unkown |
| HY-113412A | 3-Methylhistamine dihydrochloride | 99.80% | Unkown | |
| HY-145313 | TTBK1-IN-2 | Inhibitor | 99.91% | Unkown |
| HY-15805 | KIN-8194 | Inhibitor | 99.26% | Unkown |
| HY-N5106 | (E)-Flavokawain A | Inducer | 99.53% | Unkown |
| HY-W018171 | 3,5,6-Trichloro-2-pyridinol | 99.85% | Unkown | |
| HY-156856S | FL118-14-Propanol-d5 | 97.86% | Unkown | |
| HY-155157 | PF-07247685 | 98.66% | Unkown | |
| HY-21196A | Potassium perfluorohexanesulfonate | 98.0% | Unkown | |
| HY-N7271 | Solanidine | 99.90% | Unkown | |
| HY-103290 | R715 | Antagonist | 99.67% | Unkown |
| HY-N1109 | Uvaol | Inducer | 99.20% | Unkown |
| HY-P2203 | SAHM1 | Inhibitor | 96.48% | Unkown |
| HY-116538 | (10E,12Z)-Octadeca-10,12-dienoic acid | Activator | 99.10% | Unkown |
| HY-N10991 | Crocetin dialdehyde | 99.75% | Unkown | |
| HY-111358 | TLR7 agonist 1 | Agonist | 98.19% | Unkown |
| HY-101139A | Xanthine amine congener hydrochloride | Antagonist | 98.03% | Unkown |
| HY-107527 | Org 25543 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-137440 | Firazorexton | 99.56% | Unkown | |
| HY-163087 | PT-91 | Agonist | 98.78% | Unkown |
| HY-B2046 | Simazine | 99.44% | Unkown | |
| HY-N0506 | Rosarin | 99.96% | Unkown | |
| HY-N6962 | α-Spinasterol | 99.90% | Unkown | |
| HY-164546 | WB436B | 99.93% | Unkown | |
| HY-B0448S | Phenytoin-d10 | Inhibitor | 99.50% | Unkown |
| HY-108497 | L-803087 | Agonist | 99.66% | Unkown |
| HY-Y0850U6 | PVA (Mw 205000) | / | Unkown | |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | Inhibitor | 99.04% | Unkown |
| HY-N0901A | Corynoxine B | Inhibitor | 99.76% | Unkown |
| HY-116818 | Crebinostat | Inhibitor | 98.83% | Unkown |
| HY-120589 | VU0360172 | Agonist | 98.07% | Unkown |
| HY-121035 | 7BIO | Inhibitor | 99.20% | Unkown |
| HY-12242 | GBR 12935 dihydrochloride | Inhibitor | 99.80% | Unkown |
| HY-143793 | RBP4 inhibitor 1 | Inhibitor | 99.49% | Unkown |
| HY-21193 | Perfluoropentanoic acid | 98.0% | Unkown | |
| HY-P1259A | PR-39 TFA | Inhibitor | 99.89% | Unkown |
| HY-Y1809 | 1-Hydroxyoctadecane | 99.65% | Unkown | |
| HY-132302 | Hu7691 | Inhibitor | 99.91% | Unkown |
| HY-147222 | SAE-14 | Antagonist | 98.60% | Unkown |
| HY-155478 | Androgen receptor-IN-6 | Inhibitor | 98.26% | Unkown |
| HY-160237 | HYL001 | Inhibitor | 99.94% | Unkown |
| HY-164495 | Sob-AM2 | Agonist | 98.5% | Unkown |
| HY-P3102 | GLP-1(32-36)amide | 98.44% | Unkown | |
| HY-148506 | 5'-ODMT cEt m5U Phosphoramidite (Amidite) | 99.76% | Unkown | |
| HY-149449 | Poly-L-γ-glutamic acid sodium | / | Unkown | |
| HY-120000 | MS402 | Inhibitor | 98.36% | Unkown |
| HY-145774 | PD-1/PD-L1-IN-23 | Inhibitor | 99.98% | Unkown |
| HY-118282 | mPGES1-IN-7 | Inhibitor | 99.78% | Unkown |
| HY-12678S1 | Entrectinib-d8 | 99.82% | Unkown | |
| HY-136182 | YM-244769 dihydrochloride | Inhibitor | 98.57% | Unkown |
| HY-136182A | YM-244769 | Inhibitor | 99.22% | Unkown |
| HY-139659 | ARD-61 | 99.57% | Unkown | |
| HY-156374 | D359-0396 | Inhibitor | 99.98% | Unkown |
| HY-161671 | GAT2711 | Agonist | 98.00% | Unkown |
| HY-162387 | UK4b | Inhibitor | 96.17% | Unkown |
| HY-162428 | PTPN2/1-IN-3 | Inhibitor | 99.89% | Unkown |
| HY-163782 | SMIP-031 | 98.60% | Unkown | |
| HY-N2411 | Geissoschizine methyl ether | Agonist | 99.97% | Unkown |
| HY-N3522 | Platycoside E | Inhibitor | 99.40% | Unkown |
| HY-P1302 | Orphanin FQ(1-11) | Agonist | 99.83% | Unkown |
| HY-W248594 | IR 813 tosylate | 98.52% | Unkown | |
| HY-W674241 | 4-Ethylphenyl sulfate | Inducer | / | Unkown |
| HY-113354S | Anserine-d4 | 99.38% | Unkown | |
| HY-B1946S | Dimethoate-d6 | 99.86% | Unkown | |
| HY-P5489 | IGRP(206-214) | Agonist | 96.63% | Unkown |
| HY-148100 | Emapticap pegol | Inhibitor | 91.38% | Unkown |
| HY-123475A | Sisunatovir hydrochloride | Inhibitor | 98.05% | Unkown |
| HY-100935 | Cimaterol | Agonist | 99.13% | Unkown |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-121852 | SCH 336 | Agonist | 98.63% | Unkown |
| HY-143312E | (S)-V-0219 hydrochloride | Modulator | 99.71% | Unkown |
| HY-144899 | ASR-490 | Inhibitor | 99.20% | Unkown |
| HY-162866 | CXM102 | Activator | 99.36% | Unkown |
| HY-D0887 | Disodium 5'-inosinate | 99.74% | Unkown | |
| HY-N1503 | Methyl deacetylasperulosidate | 98.49% | Unkown | |
| HY-N7026 | Celosin I | 99.91% | Unkown | |
| HY-172930 | PVTX-405 | 97.07% | Unkown | |
| HY-126193 | JS-K | 99.59% | Unkown | |
| HY-126367 | Light green SF yellowish | 75.0% | Unkown | |
| HY-139973 | OAB-14 | 99.21% | Unkown | |
| HY-163729 | I-BET787 | Inhibitor | 99.88% | Unkown |
| HY-164397 | XMU-MP-5 | 99.00% | Unkown | |
| HY-173313 | Ferroptosis-IN-19 | Inhibitor | 98.92% | Unkown |
| HY-174400 | SGLT2-IN-2 | Inhibitor | 99.57% | Unkown |
| HY-N6579 | Arvenin I | 89.41% | Unkown | |
| HY-N9173 | Cupressuflavone | 99.32% | Unkown | |
| HY-P10032A | NN1177 TFA | 99.22% | Unkown | |
| HY-P10816 | PACE4 Inhibitory peptide C23 | 99.40% | Unkown | |
| HY-114853 | BVT.13 | Agonist | 98.44% | Unkown |
| HY-114992 | 2-Propyl-2-pentenoic acid | 95.0% | Unkown | |
| HY-160554 | C12-113 | 98.67% | Unkown | |
| HY-B1870 | Metaldehyde | 98.0% | Unkown | |
| HY-136522 | S2116 | 98.05% | Unkown | |
| HY-B1198S | Piperonyl butoxide-d9 | Inhibitor | 98.68% | Unkown |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-106947 | SY-640 | 99.77% | Unkown | |
| HY-107503 | MMPIP | Antagonist | 99.38% | Unkown |
| HY-117081 | C30(ω-hydroxy) Ceramide (d18:1/30:0) | 99.46% | Unkown | |
| HY-121675A | 2-Bromo-LSD D-Tartrate | 99.91% | Unkown | |
| HY-124609 | CAD031 | 99.39% | Unkown | |
| HY-129087 | BC-1258 | Inducer | 99.85% | Unkown |
| HY-130136A | TMPRSS6-IN-1 TFA | Inhibitor | / | Unkown |
| HY-14866 | Raseglurant | Modulator | 99.65% | Unkown |
| HY-155156 | PF-07238025 | 99.46% | Unkown | |
| HY-156277 | SP4f | Activator | 99.77% | Unkown |
| HY-156842 | MCAAD-3 | 98.19% | Unkown | |
| HY-157014 | TPT-004 | Inhibitor | 99.90% | Unkown |
| HY-161853 | TX-2552 | Inhibitor | 99.69% | Unkown |
| HY-162702 | AZ'3137 | Degrader | 99.90% | Unkown |
| HY-169240 | MX69-102 | Activator | 99.44% | Unkown |
| HY-173267 | CES2A-IN-2 | Inhibitor | 99.16% | Unkown |
| HY-19015 | Probimane | Inhibitor | 99.91% | Unkown |
| HY-N9794 | Isoboldine | 95.0% | Unkown | |
| HY-P1949A | Cyclic MKEY TFA | 98.47% | Unkown | |
| HY-W009688 | Dibutyl maleate | 99.19% | Unkown | |
| HY-W012837 | Benzylmethyl ether | Inhibitor | 98.70% | Unkown |
| HY-20874 | Deschlorodemethyldiazepam | 99.80% | Unkown | |
| HY-W013755 | Dioctyl phthalate | 99.40% | Unkown | |
| HY-101030A | MBM-17S | / | Unkown | |
| HY-120872 | AJS1669 free acid | Activator | 99.15% | Unkown |
| HY-153262 | (7R)-Elisrasib | Inhibitor | 99.52% | Unkown |
| HY-103177 | PSB-10 hydrochloride | Inhibitor | / | Unkown |
| HY-103327 | MJ15 | Antagonist | / | Unkown |
| HY-107504 | VU0360172 hydrochloride | Agonist | 98.94% | Unkown |
| HY-107659 | YM-244769 hydrochloride | Inhibitor | 98.09% | Unkown |
| HY-112636 | Astrophloxine | Inhibitor | 98.34% | Unkown |
| HY-113878 | 12-OAHSA | 99.0% | Unkown | |
| HY-120514 | JNc-440 | 98.04% | Unkown | |
| HY-121271 | Kadsurin | 99.38% | Unkown | |
| HY-122817 | FR900098 sodium | Inhibitor | 99.77% | Unkown |
| HY-126152 | Chlorthiamid | 95.69% | Unkown | |
| HY-12678S | Entrectinib-d4 | Inhibitor | / | Unkown |
| HY-130136 | TMPRSS6-IN-1 | Inhibitor | / | Unkown |
| HY-151876 | Glucocorticoid receptor modulator 1 | 99.79% | Unkown | |
| HY-156276 | SP4e | Activator | 99.72% | Unkown |
| HY-156936 | RCB-02-4-8 | 99.3% | Unkown | |
| HY-159972 | PKR1 antagonist 1 | Antagonist | / | Unkown |
| HY-160550 | DPM-1003 | Inhibitor | / | Unkown |
| HY-161901 | BC-1293 | Inhibitor | 98.40% | Unkown |
| HY-162765 | TRPV4-IN-5 | Inhibitor | 98.77% | Unkown |
| HY-167862A | UCM-05194 ammonium | Agonist | / | Unkown |
| HY-179474 | TSI-13-57 | Inhibitor | 98.73% | Unkown |
| HY-18164 | TASP0277308 | Antagonist | 99.00% | Unkown |
| HY-B1002R | Oxolinic acid (Standard) | Inhibitor | 97.60% | Unkown |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Activator | / | Unkown |
| HY-D1065 | NIR-H2O2 | / | Unkown | |
| HY-N3204 | Neoechinulin A | Inhibitor | 98.0% | Unkown |
| HY-N5097 | 13-Oxo-9E,11E-octadecadienoic acid | Activator | / | Unkown |
| HY-N7514 | Strictosidinic acid | Inhibitor | 95% | Unkown |
| HY-P11060 | MC38 SLP Adpgk | 97.52% | Unkown | |
| HY-P5117 | TAT-CIRP | Inhibitor | 98.32% | Unkown |
| HY-P5890A | YVAD-CHO TFA | Inhibitor | 98.48% | Unkown |
| HY-W013411 | (E/Z)-Locostatin | Control | 99.52% | Unkown |
| HY-W674241A | 4-Ethylphenyl sulfate sodium | Inducer | / | Unkown |
| HY-12242A | GBR 12935 | Inhibitor | / | Unkown |
| HY-138289 | 4-acetoxy MPT | 98.8% | Unkown | |
| HY-165014 | 2C-I-FLY hydrochloride | 99.3% | Unkown | |
| HY-169858 | Prostaglandin E2 Inhibitor 3 | Inhibitor | 99.2% | Unkown |
| HY-70062R | Pevonedistat (Standard) | 99.51% | Unkown | |
| HY-N16039 | TAN-1030A | Activator | / | Unkown |
| HY-101029A | MBM-55S | / | Unkown | |
| HY-101030 | MBM-17 | / | Unkown | |
| HY-120667 | DS-5272 | / | Unkown | |
| HY-12459 | Pyrindamycin B | Inhibitor | / | Unkown |
| HY-132302A | Hu7691 free base | Inhibitor | / | Unkown |
| HY-139798 | Iboxamycin | Inhibitor | / | Unkown |
| HY-100782 | DL-AP7 | Antagonist | / | Unkown |
| HY-10084 | CK0106023 | Inhibitor | / | Unkown |
| HY-100922 | N-Acetylglycyl-D-glutamic acid | Agonist | / | Unkown |
| HY-10109A | AS-605240 potassium | Inhibitor | / | Unkown |
| HY-101384 | Ro 10-5824 | Agonist | / | Unkown |
| HY-101699 | AMG-076 free base | Antagonist | / | Unkown |
| HY-101780A | Tinostamustine hydrochloride | Inhibitor | / | Unkown |
| HY-103357 | LY288513 | Antagonist | / | Unkown |
| HY-103567 | Desmethyl-YM-298198 hydrochloride | Antagonist | / | Unkown |
| HY-105052 | SC 34301 | / | Unkown | |
| HY-105236 | (Rac)-Enadoline | Agonist | / | Unkown |
| HY-105969 | Dichloromethotrexate | / | Unkown | |
| HY-106752 | CI-936 | Agonist | / | Unkown |
| HY-108497A | L-803087 TFA | Agonist | / | Unkown |
| HY-108538 | Ethacrynic acid D5 | Inhibitor | / | Unkown |
| HY-110020 | rel-O-2050 | Antagonist | / | Unkown |
| HY-111315 | XEN103 | Inhibitor | / | Unkown |
| HY-113354S1 | Anserine-d4 hydrochloride | / | Unkown | |
| HY-113866 | E-55888 | Agonist | / | Unkown |
| HY-113889 | ZK112993 | Antagonist | / | Unkown |
| HY-114542 | LY 201409 | / | Unkown | |
| HY-114651 | Phenazoviridin | / | Unkown | |
| HY-116046 | GR 196429 | Agonist | / | Unkown |
| HY-116597 | L-783483 | Agonist | / | Unkown |
| HY-117555 | 4010B-30 | Activator | / | Unkown |
| HY-117569 | KF24345 free base | Inhibitor | / | Unkown |
| HY-117603 | CM-10-18 | Inhibitor | / | Unkown |
| HY-117660S1 | Lincomycin-13C,d3 | Inhibitor | / | Unkown |
| HY-117836 | FAK-IN-16 | Inhibitor | / | Unkown |
| HY-118030 | RQ-00311651 | Antagonist | / | Unkown |
| HY-118032 | Bozepinib | / | Unkown | |
| HY-118426 | (Rac)-Tipifarnib | Inhibitor | / | Unkown |
| HY-118574 | UBP141 | Antagonist | / | Unkown |
| HY-118626 | PD-254552 | Inhibitor | / | Unkown |
| HY-119519 | OB-2 | Inhibitor | / | Unkown |
| HY-119899 | BO-0742 | / | Unkown | |
| HY-120171 | DH-376 | Inhibitor | / | Unkown |
| HY-120225 | NJK14047 | Inhibitor | / | Unkown |
| HY-120561 | PC-046 | / | Unkown | |
| HY-120769 | Pimprinine | Inhibitor | ≥90.0% | Unkown |
| HY-120804 | PH-46A | Inhibitor | / | Unkown |
| HY-121431 | FR-901235 | / | Unkown | |
| HY-12153 | JNJ-1930942 | Modulator | / | Unkown |
| HY-121565 | SaRI 59-801 | Activator | / | Unkown |
| HY-122179 | NUCC-555 | Antagonist | / | Unkown |
| HY-122309 | A-71497 | / | Unkown | |
| HY-122518 | 8-Deazafolic acid | Inhibitor | / | Unkown |
| HY-122655 | HMCEF | Inhibitor | / | Unkown |
| HY-122916 | 7-Acetyllycopsamine | / | Unkown | |
| HY-123020 | CYD-2-88 | Antagonist | 98.52% | Unkown |
| HY-123237 | KRC-108 | / | Unkown | |
| HY-123357 | IMM-H004 | Inhibitor | / | Unkown |
| HY-124412S | Paynantheine-d3 | / | Unkown | |
| HY-124557 | Mahanimbine | Inhibitor | / | Unkown |
| HY-126185 | Nibroxane | Inhibitor | / | Unkown |
| HY-126835 | A924 | / | Unkown | |
| HY-126910 | Mesyl Salvinorin B | Agonist | / | Unkown |
| HY-127039 | Antipain | Inhibitor | / | Unkown |
| HY-129335 | Chlorozotocin | Inhibitor | / | Unkown |
| HY-129406 | AF 698 | / | Unkown | |
| HY-129577 | Aplysin | Inhibitor | / | Unkown |
| HY-131508 | M&B 5124 | Inhibitor | / | Unkown |
| HY-131954 | 5-HT3 antagonist 4 | Antagonist | / | Unkown |
| HY-133533 | O-2050 | Antagonist | / | Unkown |
| HY-134191 | Cryptochrome modulator 1 | Modulator | / | Unkown |
| HY-143312C | (S)-V-0219 | Modulator | / | Unkown |
| HY-144668 | RdRP-IN-4 | Inhibitor | / | Unkown |
| HY-146001 | Influenza virus-IN-4 | Inhibitor | / | Unkown |
| HY-146151 | γ-Secretase modulator 12 | / | Unkown | |
| HY-146280 | mGAT3/4-IN-1 | Inhibitor | / | Unkown |
| HY-146293 | HDAC6/HSP90-IN-1 | Inhibitor | / | Unkown |
| HY-146297 | Xanthine oxidoreductase-IN-2 | Inhibitor | / | Unkown |
| HY-146401 | CXCR4 antagonist 6 | Antagonist | / | Unkown |
| HY-146435 | Anti-inflammatory agent 22 | Inhibitor | / | Unkown |
| HY-146458 | Antibacterial agent 102 | Inhibitor | / | Unkown |
| HY-146495 | Antitubercular agent-19 | Inhibitor | / | Unkown |
| HY-146496 | Antitubercular agent-20 | Inhibitor | / | Unkown |
| HY-146505 | Tubulin polymerization-IN-6 | / | Unkown | |
| HY-147335 | 6,9,12,15-Hexadecatetraenoic acid-ethyl ester | / | Unkown | |
| HY-147529 | mGluR2 modulator 3 | Modulator | / | Unkown |
| HY-147678 | GPR40 agonist 5 | Agonist | / | Unkown |
| HY-147692 | COX-2-IN-14 | Inhibitor | / | Unkown |
| HY-148038 | 5-HT3 antagonist 5 | Antagonist | 99.75% | Unkown |
| HY-148617 | ALDH2 modulator 1 | Modulator | / | Unkown |
| HY-149227 | IDO1-IN-21 | Inhibitor | / | Unkown |
| HY-149240 | Anticancer agent 108 | Inhibitor | / | Unkown |
| HY-149298 | PSMA-IN-2 | Inhibitor | / | Unkown |
| HY-149333 | BO-1 | Inhibitor | / | Unkown |
| HY-149521 | PI3K-IN-47 | Inhibitor | / | Unkown |
| HY-149776 | RGH-560 | / | Unkown | |
| HY-149940 | SIMR3030 | Inhibitor | / | Unkown |
| HY-149975 | AMPA receptor modulator-4 | Activator | / | Unkown |
| HY-150036 | Anthramycin | Antagonist | / | Unkown |
| HY-15041 | NVP-SAA164 | Antagonist | / | Unkown |
| HY-151153 | HDAC1-IN-5 | / | Unkown | |
| HY-155229 | CBP/p300-IN-21 | Inhibitor | / | Unkown |
| HY-155236 | Ancistrotecine B | Inhibitor | / | Unkown |
| HY-155328 | GK444 | Inhibitor | / | Unkown |
| HY-155329 | GK718 | Inhibitor | / | Unkown |
| HY-155529 | FD1024 | Inhibitor | / | Unkown |
| HY-155548 | RORγt inverse agonist 31 | Inhibitor | / | Unkown |
| HY-155652 | ABCG2-IN-1 | Inhibitor | / | Unkown |
| HY-155682 | Antibacterial agent 150 | Inhibitor | / | Unkown |
| HY-156792 | RIOK2-IN-1 | Inhibitor | / | Unkown |
| HY-157085 | BX-2819 | Inhibitor | / | Unkown |
| HY-157211 | Anti-inflammatory agent 66 | Inhibitor | / | Unkown |
| HY-157326 | hMAO-B-IN-6 | Inhibitor | / | Unkown |
| HY-157429 | 25N-N1-Nap | Agonist | / | Unkown |
| HY-157430 | BET-IN-21 | Inhibitor | / | Unkown |
| HY-158006 | SDX-7539 | Inhibitor | / | Unkown |
| HY-158272 | Penicillin/OVA | Inhibitor | / | Unkown |
| HY-158434 | IRAK1-IN-1 | Inhibitor | / | Unkown |
| HY-158649 | Fasnall benzenesulfonate | / | Unkown | |
| HY-159602 | BET BD2-IN-3 | Inhibitor | / | Unkown |
| HY-159891 | Microtubule destabilizing agent-2 | / | Unkown | |
| HY-159895 | PAR4 antagonist 7 | Antagonist | / | Unkown |
| HY-159941 | tau-0N4R-IN-1 | Inhibitor | / | Unkown |
| HY-159942 | 5-HT7R antagonist 3 | / | Unkown | |
| HY-160025 | IDO antagonist-1 | Antagonist | / | Unkown |
| HY-161281 | α-Glucosidase-IN-49 | Inhibitor | / | Unkown |
| HY-161372 | PARP1/c-Met-IN-1 | / | Unkown | |
| HY-161373 | PI3Kα-IN-22 | Inhibitor | / | Unkown |
| HY-161458 | GSK-3β inhibitor 16 | / | Unkown | |
| HY-161860 | Antibacterial agent 233 | Inhibitor | / | Unkown |
| HY-161863 | Tubulin polymerization-IN-67 | / | Unkown | |
| HY-161887 | SMARCA2-IN-8 | Inhibitor | / | Unkown |
| HY-161890 | Antimycobacterial agent-8 | Inhibitor | / | Unkown |
| HY-161893 | Anti-MRSA agent 15 | Inhibitor | / | Unkown |
| HY-162406 | UNC8969 | / | Unkown | |
| HY-162655A | SLF80821178 hydrochloride | Inhibitor | / | Unkown |
| HY-162703 | Lipid-lowering agent-2 | Activator | / | Unkown |
| HY-162727 | GCS-12 | / | Unkown | |
| HY-162751 | Anticancer agent 249 | / | Unkown | |
| HY-162760 | COMT-IN-1 | Inhibitor | / | Unkown |
| HY-162867 | Photosensitizer-5 | Inducer | / | Unkown |
| HY-162879 | FAK inhibitor 7 | / | Unkown | |
| HY-162893 | SX29 | Inhibitor | / | Unkown |
| HY-163003 | Antitrypanosomal agent 19 | Inhibitor | / | Unkown |
| HY-163066 | α-Glucosidase-IN-44 | Inhibitor | / | Unkown |
| HY-163300 | NLRP3-IN-30 | Inhibitor | / | Unkown |
| HY-163320 | AChE/Aβ-IN-5 | Inhibitor | / | Unkown |
| HY-163363 | β-AR antagonist 2 | Antagonist | / | Unkown |
| HY-163482 | ELQ-596 | Inhibitor | / | Unkown |
| HY-163484 | ELQ-650 | Inhibitor | / | Unkown |
| HY-163651 | (R)-Vorbipiprant | Antagonist | / | Unkown |
| HY-163797 | WRN inhibitor 10 | Inhibitor | / | Unkown |
| HY-163799 | PRMT5-MTA-IN-1 | Inhibitor | / | Unkown |
| HY-163816 | Antiproliferative agent-53-d3 | Inhibitor | / | Unkown |
| HY-163817 | PARP1/2-IN-3 | Inhibitor | / | Unkown |
| HY-163906 | Anti-MRSA agent 16 | Inhibitor | / | Unkown |
| HY-163978 | YGZ-331 | Activator | / | Unkown |
| HY-165425 | KR31173 | Antagonist | / | Unkown |
| HY-168021 | MAO-A/SERT-IN-1 | Inhibitor | / | Unkown |
| HY-168031 | AChE/BChE-IN-21 | / | Unkown | |
| HY-168444 | CDK4/6-IN-23 | Inhibitor | / | Unkown |
| HY-168742 | V1a/V2 antagonist 1 | Antagonist | / | Unkown |
| HY-169007 | STAT3-IN-34 | Inhibitor | / | Unkown |
| HY-169019 | XJTU-L453 | / | Unkown | |
| HY-169037 | Δ8-Tetrahydrocannabinoquinone | Inducer | / | Unkown |
| HY-169104 | InhA-IN-8 | Inhibitor | / | Unkown |
| HY-169394 | 5-HT1AR agonist 2 | / | Unkown | |
| HY-169928 | WRN inhibitor 14 | Inhibitor | / | Unkown |
| HY-170659 | NF-κB-IN-18 | Inhibitor | / | Unkown |
| HY-170934 | BW710 | Inhibitor | / | Unkown |
| HY-170977 | JAK1/STAT3-IN-1 | Inhibitor | / | Unkown |
| HY-171035 | PRL-295 | Inhibitor | / | Unkown |
| HY-171732 | FANFT | / | Unkown | |
| HY-172456 | JSF-4898 | Inhibitor | / | Unkown |
| HY-172674 | HPK1-IN-59 | Inhibitor | / | Unkown |
| HY-172732 | PRMT5-IN-50 | Inhibitor | / | Unkown |
| HY-172781 | HDAC6-IN-55 | Inhibitor | / | Unkown |
| HY-173316 | STING-IN-12 | Inhibitor | / | Unkown |
| HY-173347 | BLINK11 | Inhibitor | / | Unkown |
| HY-173348 | BLINK15 | Inhibitor | / | Unkown |
| HY-173471 | TRPA1 agonist-1 | Agonist | / | Unkown |
| HY-173479 | GLP-1R agonist 30 | Agonist | / | Unkown |
| HY-173518 | SIN 14 | / | Unkown | |
| HY-175042 | D-myo-Inositol-1,3,4,5,6-pentaphosphate ammonium salt | Inhibitor | 98% | Unkown |
| HY-176052 | PPO-allene | Inhibitor | / | Unkown |
| HY-176063 | TRPV1 antagonist 11 | / | Unkown | |
| HY-176288 | eIF4E/eIF4G PPI-IN-1 | / | Unkown | |
| HY-176775 | TPP-IOA | Inhibitor | / | Unkown |
| HY-179379 | EP4 receptor agonist 3 prodrug | / | Unkown | |
| HY-179463 | BKI 1708 | Inhibitor | / | Unkown |
| HY-180291 | Anti-inflammatory agent 109 | Inhibitor | / | Unkown |
| HY-180785 | G243-1720 | Inhibitor | / | Unkown |
| HY-180829 | HDAC6-IN-71 | Inhibitor | / | Unkown |
| HY-182418 | UR-11353 | / | Unkown | |
| HY-183340 | Antibacterial agent 341 | / | Unkown | |
| HY-40156A | Mycobacterium Tuberculosis-IN-5 | Inhibitor | / | Unkown |
| HY-B0693S | Ranitidine-d6 | / | Unkown | |
| HY-B1002S | Oxolinic acid-d5 | Inhibitor | 98.0% | Unkown |
| HY-B2046S | Simazine-d10 | / | Unkown | |
| HY-B2185 | Tipepidine citrate | / | Unkown | |
| HY-D1066 | NIR-Thiol dinitrobenzenesulfonate | / | Unkown | |
| HY-D1535 | IR 813 perchlorate | / | Unkown | |
| HY-D2095 | Medical fluorophore 33 | / | Unkown | |
| HY-D2988 | BIN-3 | / | Unkown | |
| HY-N0219R | Bicuculline (Standard) | Antagonist | / | Unkown |
| HY-N10312 | Yadanzigan | Inhibitor | / | Unkown |
| HY-N10341 | Centaureidin | Activator | / | Unkown |
| HY-N11021 | Feruloyl tyramine | / | Unkown | |
| HY-N11723 | Catenarin | Inhibitor | / | Unkown |
| HY-N11730 | 6',7'-Epoxyrotenone | / | Unkown | |
| HY-N12042 | Taxamairin B | Inhibitor | / | Unkown |
| HY-N12249 | 7-Deoxy-trans-dihydronarciclasine | Inhibitor | / | Unkown |
| HY-N14193 | Estatin B | Inhibitor | / | Unkown |
| HY-N15177 | Δ9-THCB | Agonist | / | Unkown |
| HY-N15703 | Norisocorydine | / | Unkown | |
| HY-N18124 | 1-O-Tigloyl-1-O-debenzoylohchinal | / | Unkown | |
| HY-N5126 | Juncusol | / | Unkown | |
| HY-N7047 | 8-Epidiosbulbin E acetate | Inhibitor | 98.42% | Unkown |
| HY-N7271R | Solanidine (Standard) | / | Unkown | |
| HY-N7944 | Eucommiol | / | Unkown | |
| HY-N9475 | Betulonaldehyde | Inhibitor | / | Unkown |
| HY-P10029 | Sakura-6 | Inhibitor | / | Unkown |
| HY-P10057 | cpm-1285 | Inducer | / | Unkown |
| HY-P10110 | retro-inverso TAT-Beclin 1 (D-amino acid) | Inducer | / | Unkown |
| HY-P10721 | Plectasin | Inhibitor | / | Unkown |
| HY-P11405 | [D-Arg1,D-Trp5,7,9,Leu11]-Substance P | Antagonist | / | Unkown |
| HY-P11431 | Cyclo(Gly-Pro) | / | Unkown | |
| HY-P11467 | Gy-CATH | / | Unkown | |
| HY-P1259 | PR-39 | Inhibitor | / | Unkown |
| HY-P1302A | Orphanin FQ(1-11) TFA | Agonist | / | Unkown |
| HY-P1949 | Cyclic MKEY | / | Unkown | |
| HY-P3102A | GLP-1(32-36)amide TFA | / | Unkown | |
| HY-P3707 | Tumor targeted pro-apoptotic peptide | Inducer | / | Unkown |
| HY-P5130 | Big endothelin-1 (rat 1-39) | Ligand | / | Unkown |
| HY-P5890 | YVAD-CHO | Inhibitor | / | Unkown |
| HY-RS08425 | MICAL1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004681 | 5-Hydroxy-2-methylpyridine | 99.97% | Unkown | |
| HY-W040276 | Diafen NN | / | Unkown | |
| HY-W097106 | (S)-3-N-Cbz-Amino-succinimide | 97.0% | Unkown | |
| HY-W1142093 | ActRIIB-IN-4 | / | Unkown | |
| HY-W331017 | 1-Hexacosanoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W744266 | 9α,10α-Epoxyhexahydrocannabinol | / | Unkown | |
| HY-W795264 | FR900098 | Inhibitor | / | Unkown |
| HY-100442S | Paquinimod-d5 | Inhibitor | / | Unkown |
| HY-100840 | (S)-4C3HPG | / | Unkown | |
| HY-101775 | 9-Hydroxyellipticin | Inhibitor | / | Unkown |
| HY-103163 | (±)-5'-Chloro-5'-deoxy-ENBA | Agonist | / | Unkown |
| HY-103388 | NCX 466 | Inhibitor | / | Unkown |
| HY-103567A | Desmethyl-YM-298198 | Antagonist | / | Unkown |
| HY-109044S | Tapinarof-d5 | Agonist | / | Unkown |
| HY-116799 | NSC 145669 | Inhibitor | / | Unkown |
| HY-117446 | AS-1669058 | Agonist | / | Unkown |
| HY-118537 | ICI 56780 | Inhibitor | / | Unkown |
| HY-118802 | 4-Hydroxy DPT | / | Unkown | |
| HY-118803 | AS1468240 | Inhibitor | / | Unkown |
| HY-119218 | LH 1 | / | Unkown | |
| HY-119955 | Amflutizole | Inhibitor | / | Unkown |
| HY-120450 | CL-55 | Inhibitor | / | Unkown |
| HY-120462 | Genz-669178 | Inhibitor | / | Unkown |
| HY-12242B | GBR 12935 fumarate | Inhibitor | / | Unkown |
| HY-124499 | RUC-1 | Inhibitor | / | Unkown |
| HY-12580 | RO5353 | MDM2 Inhibitor | / | Unkown |
| HY-12610 | Carbonic anhydrase inhibitor 27 | Inhibitor | / | Unkown |
| HY-126170 | Valanimycin | Inhibitor | / | Unkown |
| HY-127014 | Julimycin B2 | Inhibitor | / | Unkown |
| HY-129318 | MBX-1066 | Inhibitor | / | Unkown |
| HY-129347 | Lankacyclinol A | Inhibitor | / | Unkown |
| HY-134314 | 8-Nitro-cGMP | Inducer | / | Unkown |
| HY-134579 | Chaetomellic acid A | Inhibitor | / | Unkown |
| HY-138100 | Hyalodendrin | Inhibitor | / | Unkown |
| HY-138291 | Ethoxyquin dimer | 98.70% | Unkown | |
| HY-139240 | Cannabidihexol | / | Unkown | |
| HY-147548 | Keap1-Nrf2-IN-10 | Inhibitor | / | Unkown |
| HY-161728 | Antibacterial agent 223 | Inhibitor | / | Unkown |
| HY-161935 | 6-(12-Tridecene-1-yl)-2,4-Dihydroxy benzoic acid | Inhibitor | / | Unkown |
| HY-161937 | Antibacterial agent 236 | Inhibitor | / | Unkown |
| HY-164384 | DFX117 | / | Unkown | |
| HY-164462 | BHA536 | / | Unkown | |
| HY-164547 | WHN-88 | Inhibitor | / | Unkown |
| HY-168355 | Δ8-THC methyl ether | Ligand | / | Unkown |
| HY-168365 | (±)-Pellotine hydrochloride | / | Unkown | |
| HY-168368 | exo-Tetrahydrocannabivarin | Ligand | / | Unkown |
| HY-168629 | FXR agonist 9 | Inhibitor | / | Unkown |
| HY-168792 | (±)-9-Nor-9α-hydroxy Hexahydrocannabinol | / | Unkown | |
| HY-170717 | 3-Methylnordiazepam | / | Unkown | |
| HY-172335 | C9-200 | / | Unkown | |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
| HY-180360 | Antiparasitic agent-34 | Inhibitor | / | Unkown |
| HY-180936 | FBPase-IN-6 | / | Unkown | |
| HY-21193R | Perfluoropentanoic acid (Standard) | / | Unkown | |
| HY-B0448S2 | Phenytoin-d5 | Inhibitor | / | Unkown |
| HY-N12171 | Isoreserpiline | Inhibitor | / | Unkown |
| HY-N12719 | Isocampneoside I | / | Unkown | |
| HY-N13715 | Thalicminine | / | Unkown | |
| HY-N13894 | Auramycin A | Inhibitor | / | Unkown |
| HY-N13895 | Auramycin B | Inhibitor | / | Unkown |
| HY-N14018 | Glidobactin A | Inhibitor | / | Unkown |
| HY-N14200 | Maridomycin II | Inhibitor | / | Unkown |
| HY-N14201 | Maridomycin IV | Inhibitor | / | Unkown |
| HY-N14202 | Maridomycin V | Inhibitor | / | Unkown |
| HY-N14203 | Maridomycin VI | Inhibitor | / | Unkown |
| HY-N14586 | Roridin J | / | Unkown | |
| HY-N14941 | Phleomycin G | Inhibitor | / | Unkown |
| HY-N1503R | Methyl deacetylasperulosidate (Standard) | / | Unkown | |
| HY-N15180 | Corynantheidine | / | Unkown | |
| HY-N4031 | Humantenine | Chemical | 98% | Unkown |
| HY-N4243 | Neocurdione | / | Unkown | |
| HY-P0009S1 | Cetrorelix-d10 | Antagonist | / | Unkown |
| HY-P10200 | CP7-FP13-2 | Inhibitor | / | Unkown |
| HY-P4885 | Glp-amyloid-β (3-40) peptide (human) | / | Unkown | |
| HY-W188178 | N-Mitrososarcosine | / | Unkown | |
| HY-W369099 | HJC0152 free base | 98.30% | Unkown | |
| HY-W658325 | P-Decyloxyaniline | / | Unkown | |
| HY-W665796 | N-Methyl-N-nitroso-2-propanamine | / | Unkown | |
| HY-W681659 | Flutoprazepam | Inhibitor | / | Unkown |
| HY-109506S10 | DPPC-13C3 | / | Unkown |
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99123 | Anti-Mouse CD28 Antibody (37.51) | 95.00% | Unkown | |
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | Inhibitor | 99.24% | Unkown |
| HY-P99129 | Anti-Mouse CD8a Antibody (53-6.7) | Inhibitor | 98.18% | Unkown |
| HY-P990282 | Anti-Mouse CD24 Antibody (M1/69) | Inhibitor | ≥95.0% | Unkown |
| HY-P99620 | Firivumab | Inhibitor | 95.00% | Unkown |
| HY-P990812 | Anti-Mouse myeloperoxidase/MPO Antibody (6D1) | Inhibitor | 99.71% | Unkown |
| HY-P991433 | BIIB036 | Activator | / | Unkown |
| HY-P992059 | Anti-Mouse CD1d Antibody (1B1) | Antagonist | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | MICAL1 | VGNC | VGNC:63493 |
| Bos taurus | MICAL1 | VGNC | VGNC:31457 |
| Mus musculus | MICAL1 | MGD | MGI:2385847 |
| Rattus norvegicus | MICAL1 | RGD | RGD:1309386 |
| Canis familiaris | MICAL1 | VGNC | VGNC:49758 |
| Macaca mulatta | MICAL1 | VGNC | VGNC:74547 |
| Others | MICAL1 | NCBI |